Efficacy of Early Switching From Docetaxel to Cabazitaxel in Castration‐Resistant Prostate Cancer
Taketo Kawai(National Center for Global Health and Medicine), Haruki Kume(The University of Tokyo), Daisuke Yamada(International Research Center for Japanese Studies), Jun Kamei(The University of Tokyo), Kazuki Maki(The University of Tokyo), Tappei Takada(University of Tokyo Hospital), Takehiro Tanaka(University of Tokyo Hospital), Satoru Taguchi(Iwate Medical University), Jimpei Miyakawa(Kyorin University), Yuta Yamada(Yamagata University), Yoichi Fujii(The University of Tokyo), Aya Niimi(The University of Tokyo), Tohru Nakagawa(Sapporo Kosei General Hospital), Shigenori Kakutani(The University of Tokyo)
Cited by 1
Related Papers
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|703
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|438
Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes
|Annals of the Rheumatic Diseases|2015|185
A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
|PLoS ONE|2008|180
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
|Annals of the Rheumatic Diseases|2016|177